Apart from targeting carotid lesions this study further showed that LOX-1-targeted-UPSIO could be used as a potential noninvasive imaging method of LOX-1-related glomerular disease, where increased expression of LOX-1 plays an important pathogenic role. This evidence concerns the gene OLR1 and glomerular disorder.